In conclusion, Clcn3 deficiency ameliorates HFD-induced obesity, meanwhile, improves glucolipid metabolism disorders, and the impairment of insulin sensitivity, which may be because of the AMPK-Ucp1 axis. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.